Roche obesity drug enicepatide trial shows positive results
Roche Holding reported positive results for enicepatide in adults with diabetes and obesity, according to Vontobel’s Stefan Schneider, building on prior efficacy data in obese patients without diabetes.
Roche Holding reported positive results in a study of its obesity drug candidate enicepatide in adults with diabetes and obesity, according to a research note from Vontobel’s Stefan Schneider. The result builds on a previous trial that showed efficacy in obese patients without diabetes. Patients with Type 2 diabetes…